Barclays Maintains Underweight on Alvotech, Lowers Price Target to $4

Barclays analyst Glen Santangelo has maintained an Underweight rating on Alvotech (NASDAQ: ALVO) and has lowered the price target from $5 to $4. This adjustment reflects the analyst's cautious outlook on the company's performance.